We are live on ! Find out more
PLC

Peapod Lane Capital Portfolio holdings

AUM $148M
1-Year Est. Return 89.92%
This Fund
S&P 500
This Quarter Est. Return
+9.94%
1 Year Est. Return
+89.92%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$122M
AUM Growth
+$4.36M
Cap. Flow
-$1.05M
Cap. Flow %
-0.86%
Top 10 Hldgs %
30.92%
Holding
68
New
9
Increased
32
Reduced
20
Closed
6

Top Buys

Rank Stock Value
1
LAB icon
Standard BioTools
LAB
+$2.46M
2
SEG
Seaport Entertainment Group
SEG
+$1.93M
3
ARQ icon
Arq
ARQ
+$1.75M
4
KELYA icon
Kelly Services Class A
KELYA
+$1.62M
5
INGN icon
Inogen
INGN
+$1.6M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$4.86M
2
ANRO icon
Alto Neuroscience
ANRO
+$4.52M
3
BH icon
Biglari Holdings Class B
BH
+$4.12M
4
ALTO icon
Alto Ingredients
ALTO
+$2.66M
5
CLYM
Climb Bio
CLYM
+$2.64M

Sector Composition

Rank Sector Weight
1 Healthcare 20.82%
2 Industrials 20.45%
3 Consumer Discretionary 16.52%
4 Consumer Staples 9.77%
5 Real Estate 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MXCT icon
51
MaxCyte
MXCT
$126M
$926K 0.76%
+1,332,193
New +$1.24M
KZR
52
DELISTED
Kezar Life Sciences
KZR
$925K 0.76%
126,692
-7
-0% -$46
ZNTL icon
53
Zentalis Pharmaceuticals
ZNTL
$302M
$835K 0.68%
366,868
-81,993
-18% -$212K
MEI icon
54
Methode Electronics
MEI
$592M
$774K 0.63%
+140,642
New +$1.03M
CLYM
55
Climb Bio
CLYM
$804M
$740K 0.61%
108,878
-457,114
-81% -$2.64M
SEER icon
56
Seer Inc
SEER
$120M
$736K 0.6%
438,581
-31
-0% -$57
DCGO icon
57
DocGo
DCGO
$62.6M
$698K 0.57%
+1,129,194
New +$850K
MGX icon
58
Metagenomi Therapeutics
MGX
$46.3M
$683K 0.56%
516,761
+19,108
+4% +$29.7K
FTEK icon
59
Fuel Tech
FTEK
$43.7M
$582K 0.48%
478,842
+119,199
+33% +$165K
BCYC
60
Bicycle Therapeutics
BCYC
$292M
$550K 0.45%
+121,106
New +$692K
KYTX icon
61
Kyverna Therapeutics
KYTX
$484M
$336K 0.28%
40,404
-143,416
-78% -$1.19M
ANTX icon
62
AN2 Therapeutics
ANTX
$214M
$207K 0.17%
59,854
-533,542
-90% -$1.1M
BH icon
63
Biglari Holdings Class B
BH
$1.21B
– –
-12,399
Closed -$4.12M
FSP
64
Franklin Street Properties
FSP
$46.8M
– –
-614,235
Closed -$581K
GEOS icon
65
Geospace Technologies
GEOS
$75.7M
– –
-37,817
Closed -$639K
IWM icon
66
iShares Russell 2000 ETF
IWM
$83B
– –
-19,758
Closed -$4.86M
SCHL icon
67
Scholastic
SCHL
$792M
– –
-27,344
Closed -$810K
ANRO icon
68
Alto Neuroscience
ANRO
$1.11B
– –
-253,992
Closed -$4.52M
1 2
3

Similar funds

AWA
Authentikos Wealth Advisory Morgan Hill, California $148M AUM 9.86% 1-Year Est. Return
OCM
Orleans Capital Management Mandeville, Louisiana $148M AUM 24.31% 1-Year Est. Return
CWMS
Cannon Wealth Management Services Winston Salem, North Carolina $148M AUM 13.37% 1-Year Est. Return
FFS
Flavin Financial Services Melbourne, Florida $149M AUM 14.79% 1-Year Est. Return
KCM
KM Capital Management Austin, Texas $149M AUM 18.7% 1-Year Est. Return
DAC
Dutch Asset Corp Selkirk, New York $149M AUM
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
RCM
Rockbridge Capital Management Alexandria, Virginia $149M AUM 1.06% 1-Year Est. Return

Peapod Lane Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Peapod Lane Capital held 68 positions worth $122M, up 3.7% from $118M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Peapod Lane Capital's Q1 2026 filing shows 9 new, 32 increased, 20 reduced and 6 closed positions. Its largest new stake was Standard BioTools: 2,028,527 shares worth $1.86M. The largest sale was iShares Russell 2000 ETF, an estimated $4.86M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 23% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Peapod Lane Capital's largest Q1 2026 buy was Standard BioTools: 2,028,527 shares worth $1.86M.
  • Peapod Lane Capital added most to Arq in Q1 2026, an estimated $1.75M increase.
  • Peapod Lane Capital's biggest Q1 2026 reduction was Alto Ingredients, cutting an estimated $2.66M.
  • Peapod Lane Capital fully exited iShares Russell 2000 ETF in Q1 2026, selling an estimated $4.86M.
  • Peapod Lane Capital's ten largest holdings make up 31% of its $122M portfolio in Q1 2026.
  • Peapod Lane Capital opened 9 new positions and closed 6 in Q1 2026.
  • Peapod Lane Capital's portfolio value rose 3.7% quarter-over-quarter to $122M.

Based on Peapod Lane Capital's 13F filing for Q1 2026, filed 4 May 2026.